Quest Diagnostics is scheduled to release financial results for the fourth
quarter ended December 31, 2001, after the close of the stock market on January
28, 2002. The company is currently in a "quiet" period and is scheduled to
discuss results for the fourth quarter during a conference call on January 29 at
8:00 a.m. Eastern Time. To hear a simulcast of the call over the Internet or a
replay, registered analysts may access StreetEvents at:
http://www.streetevents.com; and all others may access the Quest Diagnostics
website at: http://www.questdiagnostics.com. In addition, a replay of the call
will be available from 10 a.m. on January 29 through 5 p.m. on January 31 to
investors in the U.S. by dialing 800-754-7906. Investors outside the U.S. may
dial 402-220-0366. No password is required for either number.
Quest Diagnostics is the nation's leading provider of diagnostic testing,
information and services with $3.4 billion in annual revenues. The company's
diagnostic testing yields information that enables health care professionals and
consumers to make better decisions to improve health. Quest Diagnostics offers
patients and physicians the broadest access to diagnostic testing services
through its national network of approximately 30 full-service laboratories, 150
rapid response laboratories and more than 1,300 patient service centers, where
specimens are collected. Quest Diagnostics is the leading provider of esoteric
testing, including gene-based testing, and is the leader in routine medical
testing, drugs of abuse testing, and non-hospital-based anatomic pathology
testing. Quest Diagnostics empowers health care organizations and clinicians
with state-of-the-art connectivity solutions that improve practice management.
Through partnerships with pharmaceutical, biotechnology and information
technology companies, Quest Diagnostics provides support to help speed the
development of health care insights and new therapeutics. Additional company
information can be found on the Internet at: http://www.questdiagnostics.com.
The statements in this press release which are not historical facts or
information may be forward-looking statements. These forward-looking statements
involve risks and uncertainties that could cause the outcome to be materially
different. Certain of these risks and uncertainties are listed in the Quest
Diagnostics Incorporated 2000 Form 10-K and subsequent filings.
MAKE YOUR OPINION COUNT - Click Here
http://tbutton.prnewswire.com/prn/11690X69562890
CONTACT: Media - Gary Samuels, +1-201-393-5700, Investors - Cathy
Doherty, +1-201-393-5030, both of Quest Diagnostics Incorporated
URL: http://www.questdiagnostics.com
http://www.prnewswire.com
Copyright (C) 2002 PR Newswire. All rights reserved.